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 INTRODUCTION: 
Bacillus cereus 
 Bacillus cereus (B. cereus) is a Gram-positive, rod- shaped, aerobic- to 
facultatively anaerobic bacterial species [1] that belongs to the Bacillus cereus group, 
which also consists of B. anthracis, B.thuringiensis, and B. weihenstephanensis [2]. 
These three bacterial species are very similar phenotypically. In fact, B.thuringiensis 
can only be differentiated from B. cereus by the presence of genes coding for 
insecticidal proteins (Cry toxins) in the former. Cry toxins are crystalline structured 
proteins that have been used in commercial insecticides since the mid 1900s [3]. B. 
cereus  had long been regarded as simply a contaminant in clinical samples, and a 
spoilage organism in food products[1]. However, in the last 50 years, B. cereus has 
been found to cause a plethora of human infections. Presently, B. cereus is most 
commonly associated with gastrointestinal illnesses such as emesis and diarrheal 
syndrome. This type of intoxication or toxico-infection generally occurs through the 
ingestion of viable endospores or vegetative cells from contaminated food at densities 
at or above ~105/g.  
The high-throughput nature of the dairy industry necessitates sensitive and 
selective assays to rapidly detect pathogens. According to the CDC, an estimated 48 
million cases of foodborne illnesses occur each year. It is unclear how many cases 
occur worldwide due to the fractured nature of the data, as well as the prioritizing of 
particular foodborne organisms [4]. The presence of unwanted organisms in food not 
only poses a risk to public health, but also costs food industries millions of dollars a year 
due to food spoilage, or undesired physical changes to a food product that make it no 
longer edible. Even with modern preservation practices, approximately 25% of food is 
lost in the United States due to microbial spoilage. 
The ubiquitous nature of Bacillus cereus combined with its ability to produce 
endospores that are highly adhesive makes these bacteria an ever present problem in 
food production, packaging, and shipment/storage [5]. Furthermore, although the 
optimum temperature for a vegetative B. cereus cell is between 35 and 40oC, the 
endospores formed by B. cereus are resistant to high temperatures and desiccation, 
allowing them to survive many quality control practices such as pasteurization and 
dehydration. Subsequently, even if pasteurization effectively kills all viable cells, when 
the process is complete the undamaged endospores germinate into viable cells that are 
able to cause disease.  
B. cereus relies heavily on exoenzymes as well as enterotoxins to cause tissue 
destruction [1]. B. cereus has been found to produce three pore-forming enterotoxins, 
and one heat stable emetic toxin. Hemolysin BL (HBL), nonhemolytic enterotoxin 
(NHE), and cytotoxin K are secreted when vegetative cells, or endospores are ingested. 
Once released, these enterotoxins induce diarrheal syndrome. Conversely, the emetic 
toxin, termed cereulide, can be formed in food products, and excreted, thus B. cereus 
can still cause emesis even if no viable cells are ingested.  B. cereus has also been 
found to cause infections of the lungs eye, skin, liver, heart, central nervous system and 
urinary tract using many of the same toxins.  
 
 
Bacteriophages 
 Bacteriophages (phages) are viruses that have bacterial hosts. Phages are 
numerous and make up the largest group of viruses, having been detected in a myriad 
of natural environments [6]. Phages exhibit a wide range of morphologies, including, 
tailed, filamentous, cubic, and pleomorphic Phages are also characterized based on 
genomics (Table 1). Phage genomes may be either RNA or DNA, and either can be 
single stranded or double stranded. RNA phages can be further characterized by 
whether or not their genomes are segmented, or packaged in fragments within the 
capsid [7]. 
  
Lytic vs Lysogenic Replication Cycles: 
Phages can be further grouped based on the type of replication cycle they 
undergo [8]. For example, some phage can be virulent while others are termed 
temperate. If a phage is virulent, it is only able to undergo a lytic replication cycle, 
wherein the phage would attach to its bacterial host, and inject its genetic material into 
the bacterium. Once inside, the phage hijacks the cell’s machinery to translate phage 
proteins. Once the proteins are made, they are assembled within the host, and the fully 
assembled phages are released through lysis of the host. The process then repeats 
when the mature phage recognizes another host cell, attaches, and enters. Phages can 
also be temperate. A temperate phage undergoes lysogenic replication.  
Lysogenic replication differs from lytic replication in that the phage can undergo 
an alternate pathway that does not involve immediate lysis of the host. The phage must 
still recognize and attach to its host bacterium, as well as inject its genetic material into 
the host. Once injected, the phage DNA may become incorporated into the bacterial 
host’s genome, generating a prophage. If this happens, the bacterium can replicate 
normally many times until a specific environmental stressor occurs, triggering lysogenic 
induction, which leads back to the lytic pathway. Lytic phages are often easier to find, as 
they can be detected through simple plaque formation assays much more quickly than 
lysogenic phage (Figure 1).  
  
 
Phage Therapy and Biocontrol: 
 Phages also have a very specific host range, and are often only able to infect 
and lyse a single species or subspecies of bacteria [5]. Because of this selective 
toxicity, they have been considered as a possible way to treat bacterial infections in 
humans and other animals. This treatment is called phage therapy, and has been 
investigated essentially since phages were discovered [8]. The selectively toxic nature 
of many phages means that not only would the patient receiving treatment not be 
Figure 1: The lytic and lysogenic cycles of a lambda phage. The steps of these cycles are relatively 
conserved among most types of phages. 
(http://www.nature.com/nrg/journal/v4/n6/full/nrg1089.html) 
affected, but nontarget beneficial bacteria would also be unaffected by treatment. The 
killing of nontarget commensal bacteria has long been a problem with many antibiotic 
treatments, making phage theoretically a better alternative in this instance.  Another 
characteristic of phages that make phage therapy an attractive means to treat infection 
is their ability to coevolve with their host, reducing the occurrence of phage-resistant 
bacteria. Phages can also be used to reduce the number of bacteria in areas outside of 
medicine, like the food industry. This type of treatment is termed phage biocontrol. In 
the past, phages as a therapy or as a biocontrol agent were studied, but with the 
emergence and spread of antibiotic resistance, interest in phages has increased [9]. 
Phages are most effective when used in cocktails, which is a mixture of different 
phages that have the same host. Using a cocktail not only further reduces the risk of 
host resistance, but improves the efficacy of treatment by widening host range, and the 
mechanism of lysis [10]. The phage based treatment Listshieldtm is the first 
commercially available product to use a phage cocktail to treat listeria in meat .Phage 
cocktails have also been used as biocontrol methods for other bacteria, such as E. coli 
in meat products [11] Salmonella in livestock [12]. 
 
Setbacks and Concerns for Phage Therapy: 
Some concerns still exist when it comes to implementing phage control. The first 
is that many factors have influence over the ability of phage to lyse host cells - i.e., 
temperature, pH, and bacterial density [10]. Even the slightest deviation from the 
phage’s preferred conditions can result in ineffective treatment. Whether the phages are 
being used to treat humans, animals or animal products, these factors cannot always be 
controlled or predicted. Additionally, if the phage is a temperate phage, it is difficult to 
predict which cycle the phage will undergo, further making therapy less effective and 
predictable. Another concern is the unwanted transfer of virulence genes to host 
bacteria [9]. Many bacteria develop virulence factors as a result of the presence of a 
prophage that has been incorporated into the bacterial genome through lysogeny. It is 
possible that during the phage replication process, horizontal gene transfer could 
spread virulence factors. Both of the abovementioned problems can be reduced if not 
eliminated by carefully selecting the phages in each cocktail and not including any 
temperate phages.  
There are also concerns with phage gene activity occurring within mammalian 
cells. Mammalian cells have also been found to take up phage DNA and incorporate it 
into their genomes [9]. When given phages orally, it was found that a small number cells 
in the digestive tract of mice took up the phage DNA and could even incorporate it into 
their genomes. However, due to the vastly different cellular mechanisms between a 
eukaryotic cell and a bacterial cell, there is no indication that the intricate processes 
required for phage replication could occur in a eukaryotic cell.  
Phages as a Detection Assay for Bacteria: 
 Many of the same factors that make a phage an attractive candidate for 
the reduction of bacteria in an environment also make them a good candidate for 
detecting unwanted bacteria. The sensitive and selective nature of phages, as well as 
their sheer abundance and diversity make them a favorable tool for the detection of 
almost any kind of bacteria [13]. Generally, most assays used to detect pathogenic 
bacteria are lengthy. This is due to the need for an enrichment and/or an amplification 
step to allow the bacteria to become more numerous and reach detectable levels. 
Because of the highly efficient nature of the food processing industry, time is valuable 
when testing for pathogens and food spoilage organisms. The sensitivity of most 
phages, when applied to a detection assay, could reduce the time needed to detect 
such bacteria. Phage based detection assays already exist for bacteria such as E. coli 
O157:H7, Mycobacterium tuberculosis and Listeria.  Furthermore, phage based 
detection assays have been developed to detect spores of the highly infectious Bacillus 
anthracis. We have found no literature, however on a phage-based method to detect 
Bacillus cereus spores in food. 
The aim of this study was to screen both milk and soil samples for novel phages 
that infect Bacillus cereus, which could be studied further as prospective candidates to 
be used in phage therapy or phage detection assays within the dairy industry. We were 
able to isolate one phage from the milk of a dairy cow that was diagnosed with mastitis 
caused by Bacillus cereus. We then anticipated to be able to sequence parts of its 
genome and compare it to other known phages on Genbank, and characterize it 
morphologically using electron microscopy. 
 
  
 
 
 
 MATERIALS AND METHODS: 
 
PHAGE ISOLATION: 
Soil Samples: 
In order to collect samples to screen for phages, locations around Ball State University 
were selected. Locations of soil samples were selected with the main priority being 
diversity in soil type. Samples were collected by using a sterile scoopula to dig 
approximately 1 inch into the soil. The mass of soil collected varied due to the soil 
composition. Once collected, samples were immediately added to equal volume of 
phage buffer (10 mM Tris-HCl, 10 mM  MgSO4, 1 mM CaCl₂, 6.85 mM NaCl). The 
samples were then inoculated with early log phase Bacillus cereus ATTC14579 (VWR, 
West Chester, PA) in a liquid culture of 2X Tryptic Soy Broth (TSB) (Weber Scientific, 
Hamilton, NJ) and allowed to incubate for 12 hours at 23oC. This enrichment step was 
to increase the likelihood of detecting phages if they were present in low numbers. After 
enrichment the samples were centrifuged at 4000 x g for 1 minute to sediment the 
solids. Next, each sample was divided into two aliquots. One of these aliquots was 
filtered through a 0.2 micron filter, and the other was unfiltered in order to not miss 
prophages. The samples were added to equal parts of a 12 hour broth culture of 
Bacillus cereus ATTC14579 and incubated for 12 hours at 37oC shaking at 150 rpm.  
Milk Samples: 
Milk Samples were collected from All Wright Dairy farms in Muncie Indiana. 
Cows were chosen at random with the exception of one that had been diagnosed with 
mastitis caused by Bacillus. Raw milk was collected directly from the udder of the cow 
into a sterile container and maintained at 4 deg. C until being processed in the 
laboratory. The milk samples were immediately returned to the lab and inoculated with 
late log phase Bacillus cereus ATTC14579 in 2X TSB, and incubated for 12 hours at 
37oC shaking at 150 rpm. From this point on, the milk samples were treated the same 
as the soil samples with the omission of the centrifugation step. 
 
Plating Samples: 
One milliliter of each sample was added to 10 mL of molten Tryptic Soy Agar 
(TSA) (Weber Scientific). Calcium chloride was added to a final concentration of 5mM, 
as well as 500 mL of 4 hour Bacillus cereus in 2X TSB. The molten agar tube was then 
overlaid on a plate of TSA. Once solidified, the plates were incubated at 23oC and then 
incubated for 24 hours. After 24 hours the plates were inspected for plaques. Plaques 
were purified by lifting a single plaque from the agar, adding it to late log phase Bacillus 
in 2X TSB, plating as described above. Plaques were purified 3 times.  
 
DNA EXTRACTION: 
Individual plaques were selected, lifted, and added to late log phase Bacillus 
cereus along with a final concentration of 5mM CaCl2, and incubated at 37oC shaking at 
150 RPM for 24 hours. Next, the samples were placed in the centrifuge and spun at 
14,000 x g for 10 minutes at room temperature. The supernatant was retained in a 
separate tube. The pellet was resuspended in water, and treated with lysozyme and 
proteinase K for one hour at 37oC in order to lyse host cells and release the prophage if 
present. Next, a spin column based phage DNA extraction kit (Norgen Biotek Corp. 
Ontario, Canada) was used to extract DNA from the treated pellet and the supernatant 
according to manufacturer’s instructions. 
REAL-TIME PCR AMPLIFICATION: 
The purified phage DNA was then amplified using real-time PCR. Reagents for 
PCR are listed in Table 2. The below primer set was previously used to detect GIL01, a 
gene that has been found in prophages within Bacillus thuringiensis [14]. PCR 
parameters included 40 cycles of denaturation at 94oC, annealing at 55oC, extension at 
72oC, and a melt curve analysis was generated at the end of every extension cycle.  
 
 
Table 2: Reagents and primer sets used for PCR amplification. 
 
Reagents: SYBR Green (Sigma-Aldrich, St. Louis, MO) 
 2X Sensimix (Bioline, Taunton MA) 
 1.75 mM MgCl2 
 0.5 µg DNA template 
Primers: 5′-GGATCCATGTTGACGCCAAGGG 
 5′-AAGCTTCAGTCATCCTTCTTCCC 
 
 
DNA SEQUENCING: 
 
DNA was sent along with the above primers to the genome center at UC Davis for 
sequencing, however it was found that we were unable to collect enough quality phage 
DNA for sequencing.  
 
 
 
 
 
 
 DISCUSSION: 
Due to technical difficulties, and limited time and resources, we were unable to 
isolate quality phage DNA for sequencing, nor were we able to characterize the phage 
morphologically through electron microscopy in the two year timespan. The project was 
inherited by an incoming student, who has since been working on sequencing, and host 
range and phage sensitivity (outlined in future directions) , as well as sequencing of the 
genome.   
FUTURE DIRECTIONS: 
Study 1: Testing the ability of our novel bacteriophage to lyse Bacillus cereus cells. 
Rationale: We hypothesize that the phage we discovered could be used in a cocktail as 
a way to safely reduce the number of pathogenic Bacillus cereus in dairy products. A 
cocktail is a mixture of several different phages introduced into an environment [15]. 
Although the use of phages in the food industry is being explored, there have been few 
studies done studying the effectiveness of phage cocktails on Bacillus cereus in dairy 
products. Furthermore, since there is such variety among families of phages, it is 
important to test the lytic properties for each.  
 To make a good candidate for cocktails in this study, the phage must quickly go 
into the lytic phase, and not become lysogenic for long periods of time. It is important to 
test the time it takes a phage to lyse the host cell because if phages are added to 
cocktails that do not lyse quickly enough, they essentially are dead weight. This study 
could be used to determine the time it takes the phage discovered in our previous study 
to lyse a Bacillus cereus cells in a liquid culture. In order to be considered effective for 
our purposes: the phage must be able to lyse all bacteria in a given sample within three 
hours.  
STUDY 1 DESIGN OVERVIEW: In order to test the lytic properties of our bacteriophage, we 
would grow B. cereus ATTC 14579 in a liquid culture as previously described, and 
inoculate the broth culture with 109 P.F.U [16], and record optical density, taking 
recordings every 20 minutes for 2 hours: after 2 hours take OD readings every 5 
minutes for 30 minutes. As soon as a decrease in optical density is observed we would 
begin taking readings every 5 minutes until the optical density is consistent for three 
consecutive readings.  
POSITIVE EXPECTED OUTCOME: We would expect the optical density to begin to decrease 
once the phage has had time to go through the lytic cycle (Figure 1). The trend should 
be that as the phages infect the bacterial cells, the OD will remain constant. Once the 
cells begin to go through lytic phase, the OD will begin to steadily drop. As the phages 
replicate within the cells, and they become more numerous the OD will drop at a quicker 
rate as they lyse more cells. Eventually all of the cells will have been lysed, and the OD 
will remain constant. 
We expect to see the same trend in the lysozyme positive control. In the negative 
control we expect to see an increase in OD as the bacterial cells continue to divide. 
 CONTINGENCY PLAN: It is possible that our hypothesis will prove to be null, the phage that 
previously collected will not be able lyse B. cereus within three hours. If this occurs, we 
would deal with it in two ways. The first, is to go back to environmental sampling. As 
previously stated, phages are quite numerous, and therefore it is still possible that some 
phages that have not yet been identified will meet our criteria. The second method 
would be to look back through the literature at cocktails that have been used in the past 
with phages that have not been characterized, test the phages individually, and 
combine the most effective ones in a single cocktail. 
Study 2: Determination of host range of a novel phage found to infect Bacillus cereus 
RATIONALE: In addition to being able to quickly lyse B. cereus, we concluded that an 
optimal candidate for a phage cocktail would also need to have a very narrow range of 
hosts to ensure that only toxigenic strains of Bacillus are being targeted. Most phages 
only infect one species of bacteria [5]. However we want to ensure that none of the 
phages are able to infect hosts of the same genus but different species. 
STUDY 2 DESIGN OVERVIEW: In order to determine the host range, we would use the agar 
overlay method described above. Instead of Bacillus cereus, we would plate other 
members of the Bacillus genus that are closely related to B.cereus. Plaques will only form 
if the phage can infect this species of Bacillus. Since we previously discovered this phage 
using Bacillus cereus ATCC14579, an appropriate positive control would be to plate the 
phages on a lawn of Bacillus cereus ATCC14579. As a negative control, we will plate 
Bacillus cereus ATCC 14579 with no phages. As test organisms, Bacillus subtillis, 
Bacillus thuringiensis subspecies israelnsis and Bacillus thuringiensis var kurstaki could 
be used. These were chosen for their genetic and phenotypic relatedness to Bacillus 
cereus but they are not known human pathogens [2]. 
POSITIVE EXPECTED OUTCOME: If the results go according to plan, there should be no 
plaques on any of the plates except for the plate containing Bacillus cereus. The 
plaques, as mentioned, can vary in size, but the top layer of agar should appear turbid, 
and a plaque will appear to be a small circular clearing. It is possible, however that the 
phage could infect multiple hosts. If this were the case, the phage would not be 
excluded from being a possibility for a cocktail, but it would mean that is less desirable 
from one that does not infect any of these bacteria besides Bacillus cereus.  
 
CONTINGENCY PLAN: As mentioned in study 1, it is possible that the phage we have 
identified will not fit our parameter for host range. In this instance, we would again go 
back to environmental sampling. We believe that is the preferred method to find new 
cocktail prospects, because it also allows us to discover uncharacterized phages that 
are possibly more effective at lysis of B. cereus. If that proves to be unsuccessful, we 
could again comb through the literature and find phages that have been successfully 
used in cocktails, test them, and combine the phages that meet our criteria. 
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